InvestorsHub Logo
Followers 23
Posts 1816
Boards Moderated 0
Alias Born 11/25/2006

Re: None

Wednesday, 11/24/2021 3:41:16 PM

Wednesday, November 24, 2021 3:41:16 PM

Post# of 3353
$BCLI Important Notes
From Q1 2021 Earnings Call Transcript
Chaim Lebovits: Given the important changes, we are in active dialogue with regulators around our regulatory plan and we will share this as soon as appropriate.

Chaim Lebovits: We cannot get talked to the EAP results. Very warming to hear what you're saying, you're describing. And I do hope that we should be able to share with you some good news very soon.

David Setboun: We are actively engaging with a variety of potential partners, which include mid-sized and leading pharmaceutical companies.

Chaim Lebovits: Looking forward for a very exciting quarter.

Add to that

Senate List 48 sponsors for S.1813 - Accelerating Access to Critical Therapies for ALS Act.
500 Million
"For purposes of carrying out this Act, there are au theorized to be appropriated $100,000,000 for each of fiscal years 2022 through 2026. "

BCLI: Biomarkers Predict Response in ALS Phase 3 Trial
https://www.yahoo.com/now/bcli-biomarkers-predict-response-als-102400354.html

Zacks Small-Cap Research Sets $11 Valuation

Maybe Positive Peer Review

Please add to the list, if you have any...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCLI News